A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Sodium aurothiomalate
Potassium may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lixisenatide
Potassium may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Idarucizumab
Potassium may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Imidafenacin
Potassium may increase the excretion rate of Imidafenacin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Gimeracil
Potassium may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Tegafur
Potassium may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Dextran
Potassium may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Toloxatone
Potassium may increase the excretion rate of Toloxatone which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Pirlindole
Potassium may increase the excretion rate of Pirlindole which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Melperone
Potassium may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Blonanserin
Potassium may increase the excretion rate of Blonanserin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Piracetam
Potassium may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Pholcodine
Potassium may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Moxisylyte
Potassium may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lorpiprazole
Potassium may increase the excretion rate of Lorpiprazole which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Viloxazine
Potassium may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Technetium Tc-99m pyrophosphate
Potassium may increase the excretion rate of Technetium Tc-99m pyrophosphate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Technetium Tc-99m exametazime
Potassium may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Iopromide
Potassium may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Florbetapir (18F)
Potassium may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3